Literature DB >> 21782535

Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis.

Alfredo Marzano, Andrea Marengo, Milena Marietti, Mario Rizzetto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782535     DOI: 10.1016/j.dld.2011.06.013

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  10 in total

Review 1.  Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Lactic Acidosis during Entecavir Antiviral Treatment in a Patient with Hepatitis B Virus-related Decompensated Cirrhosis.

Authors:  H Mao; T Kang
Journal:  West Indian Med J       Date:  2015-01-27       Impact factor: 0.171

Review 3.  Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.

Authors:  Jia-Lin Jin; Piao Hu; Jia-Hong Lu; Su-Shan Luo; Xiao-Yun Huang; Xin-Hua Weng; Ji-Ming Zhang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 4.  A case of entecavir-associated bullous fixed drug eruption and a review of literature.

Authors:  Selami Aykut Temiz; İlkay Özer; Arzu Ataseven; Sıddıka Fındık
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

5.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

6.  Treatment of hepatitis B virus cirrhosis.

Authors:  Mario Rizzetto
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

Review 7.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18

8.  Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

Authors:  Robert Perrillo; Maria Buti; Francois Durand; Michael Charlton; Adrian Gadano; Guido Cantisani; Che-Chuan Loong; Kimberly Brown; Wenhua Hu; Juan Carlos Lopez-Talavera; Cyril Llamoso
Journal:  Liver Transpl       Date:  2013-08       Impact factor: 5.799

Review 9.  Update on entecavir in the management of severe forms of Hepatitis B.

Authors:  Rodolfo Sacco
Journal:  Hepat Med       Date:  2012-05-15

Review 10.  Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.

Authors:  Wei-Lun Tsai; Wei-Chi Sun; Jin-Shiung Cheng
Journal:  Int J Mol Sci       Date:  2015-11-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.